These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14699093)

  • 41. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of neurons and astrocytes by thrombin and protease nexin-1. Relationship to brain injury.
    Cunningham DD; Donovan FM
    Adv Exp Med Biol; 1997; 425():67-75. PubMed ID: 9433490
    [No Abstract]   [Full Text] [Related]  

  • 43. The serpin protease-nexin 1 is present in rat aortic smooth muscle cells and is upregulated in L-NAME hypertensive rats.
    Bouton MC; Richard B; Rossignol P; Philippe M; Guillin MC; Michel JB; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):142-7. PubMed ID: 12524238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
    Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
    Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maspin inhibits cell migration in the absence of protease inhibitory activity.
    Bass R; Fernández AM; Ellis V
    J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmin induces apoptosis of aortic valvular myofibroblasts.
    Kochtebane N; Choqueux C; Passefort S; Nataf P; Messika-Zeitoun D; Bartagi A; Michel JB; Anglés-Cano E; Jacob MP
    J Pathol; 2010 May; 221(1):37-48. PubMed ID: 20186923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.
    Low DA; Baker JB; Koonce WC; Cunningham DD
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2340-4. PubMed ID: 7017731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I.
    Bergman BL; Scott RW; Bajpai A; Watts S; Baker JB
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):996-1000. PubMed ID: 3513169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
    Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
    J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H; Vaheri A
    Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
    Festuccia C; Guerra F; D'Ascenzo S; Giunciuglio D; Albini A; Bologna M
    Int J Cancer; 1998 Jan; 75(3):418-31. PubMed ID: 9455804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease: different properties compared with protease nexin I.
    Kitaguchi N; Takahashi Y; Oishi K; Shiojiri S; Tokushima Y; Utsunomiya T; Ito H
    Biochim Biophys Acta; 1990 Mar; 1038(1):105-13. PubMed ID: 2180485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of serpins and their cognate proteases in muscle after crush injury.
    Festoff BW; Reddy RB; VanBecelaere M; Smirnova I; Chao J
    J Cell Physiol; 1994 Apr; 159(1):11-8. PubMed ID: 8138578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
    Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
    Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protease nexins: cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases.
    Knauer DJ; Thompson JA; Cunningham DD
    J Cell Physiol; 1983 Dec; 117(3):385-96. PubMed ID: 6317700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia.
    Docagne F; Nicole O; Marti HH; MacKenzie ET; Buisson A; Vivien D
    FASEB J; 1999 Aug; 13(11):1315-24. PubMed ID: 10428756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.